Houston, TX, United States of America

Rick Barsky

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Rick Barsky

Introduction

Rick Barsky is an accomplished inventor based in Houston, TX. He has made significant contributions to the field of medical treatments, particularly in the area of cancer therapies. With a total of two patents to his name, Barsky's work focuses on innovative methods to combat hyperproliferative diseases.

Latest Patents

Rick Barsky's latest patents include groundbreaking research on the use of lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases. The present invention relates to methods of treating a hyperproliferative disease by administering a composition of lactoferrin alone or in combination with standard anti-cancer therapies. This innovative approach aims to enhance the effectiveness of existing cancer treatments.

Career Highlights

Throughout his career, Barsky has been associated with Agennix Incorporated, where he has played a pivotal role in advancing cancer treatment methodologies. His dedication to research and development has positioned him as a key figure in the medical innovation landscape.

Collaborations

Rick Barsky has collaborated with notable professionals in his field, including Atul Varadhachary and Federica Pericle. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in cancer research.

Conclusion

Rick Barsky's contributions to the field of medical innovation, particularly in cancer treatment, highlight his commitment to improving patient outcomes. His work with lactoferrin represents a significant step forward in the fight against hyperproliferative diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…